31 Mar 2023
Assets14.73
Total Income28.97
EBITDA1.61
Profit After Tax1.31
NET Worth6.56
Reserves and Surplus6.49
Total Borrowing1.21
At a glance
Updated 2026-08-24The shares listed at ₹135.50, a 0.37% move from the issue price. Earkart is a SME IPO with an issue size of ₹49.26 crore, proposed for listing on BSE SME. The offer opens on 25th Sep 2025 and closes on 29th Sep 2025. The issue structure includes a fresh issue of ₹42.26 crore and an offer-for-sale component of ₹4.51 crore. The current listing schedule points to 3rd Oct 2025.
Issue details
Listing atBSE SME
Issue typeFixed Price Issue
Issue size₹49.26 Cr
Fresh issue₹42.26 Cr
Offer for sale₹4.51 Cr
Face value₹10
Price band—–—
Allotment30th Sep 2025
Listing3rd Oct 2025
Listing performance
Full performance ↗Issue price₹135.00
Listing price₹135.50
Current price—
Listing gain0.37%
Current return—
Price progressionIssue → Listing → Current
Grey market
GMP page ↗Latest GMP₹0.00
GMP / upper priceNO DATA
Est. listing₹135.00
GMP is unofficial sentiment data, not an exchange price.
Timeline
Opens25th Sep 2025
Closes29th Sep 2025
Allotment30th Sep 2025
Refund1st Oct 2025
Demat1st Oct 2025
Listing3rd Oct 2025
Subscription demand
Full bidding ↗Total1.28×
Lot size
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 2000 | — |
Company
Use of proceeds
| Object | Amount |
|---|---|
| Funding incremental working capital requirements of Company | ₹21.10 Cr |
| Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities | ₹17.33 Cr |
| General Corporate Purposes | ₹0.63 Cr |
| Issue Expenses | ₹6.26 Cr |
| Total | ₹45.33 Cr |
Financials
Full financials ↗31 Mar 2024
Assets19.25
Total Income31.97
EBITDA3.55
Profit After Tax3.06
NET Worth13.03
Reserves and Surplus12.97
Total Borrowing4.00
31 Mar 2025
Assets30.29
Total Income43.19
EBITDA9.76
Profit After Tax6.88
NET Worth19.92
Reserves and Surplus9.48
Total Borrowing4.96
Trend chart₹ crore
KPIs
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 34.55% |
| ROCE | 47.32% |
| Debt / Equity | 0.26% |
| RoNW | 34.55% |
| PAT Margin | 15.93% |
| EBITDA Margin | 22.65% |
| Price to Book Value | 7.08 |
Valuation & shareholding
Pre-IPO EPS6.59
Post-IPO EPS5.00
Pre-IPO P/E20.48
Post-IPO P/E26.98
Promoter holding pre78.75%
Promoter holding post57.34%
Market cap₹185.68 Cr.
Issue expenses
| Expense | Amount |
|---|---|
| Funding incremental working capital requirements of Company | ₹21.10 Cr |
| Funding capital expenditure requirements for setting of Shop in Shop (SIS) Business Model in ENT/Ophthalmic Clinics across India and Setting up of Infrastructure for operational activities | ₹17.33 Cr |
| General Corporate Purposes | ₹0.63 Cr |
| Issue Expenses | ₹6.26 Cr |
| Total | ₹45.33 Cr |
Registrar & lead managers
Registrar
Skyline Financial Services Pvt.Ltd.Lead managers
- Sarthi Capital Advisors Pvt.Ltd.
Offer documents
Data is reconciled from multiple public IPO sources. Official exchange filings and offer documents remain the source of truth. Last verified 2026-08-24.